Ever wondered if ResMed stock is actually a steal or quietly overhyped? You're not alone. This article will dig beneath the surface to find out. Shares have seen modest gains recently, with the price ...
StockStory.org on MSN
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an ...
The latest update on Wednesday morning shows ResMed shares down by 0.02%, trading at $246.16. At this price, Farrell's 11,442 ...
Discover why ResMed is a top buy with strong fundamentals, robust cash flow, and dividend potential—ideal for recession-proof ...
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated ...
Resmed, a global leader in digital health and sleep technology, has launched a new film under its awareness campaign, “Don’t ...
TipRanks on MSN
ResMed Streamlines Governance at Annual Meeting
On November 19, 2025, ResMed Inc. held its annual meeting where significant decisions were made regarding the company’s governance and operational plans. Richard Sulpizio’s te ...
Expands ResMed’s out-of-hospital software portfolio into skilled nursing and senior living verticals Enhances ResMed’s ability to improve patient transitions of care and provider efficiencies Purchase ...
For the past 18 months, ResMed Chief Executive Mick Farrell has been publicly outspoken in urging that medical devices get priority access to semiconductors amid global chip shortages coming out of ...
SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today announced it will host an investor meeting on Thursday, April 4 th to discuss the Company’s recent acquisitions, existing joint ventures ...
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only. A replay of the earnings webcast will be accessible on ...
With the pandemic-induced chip shortage still ballooning around the world, ResMed has been forced to deflate its expectations for what it hoped to reap in the vacuum caused by Philips’ major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback